HPV Vaccines
Many adolescents, adults and healthcare providers have a limited understanding of human papillomavirus (HPV) infections, particularly those that are sexually transmitted. Further, many are uninformed about the links between genital HPV infection, abnormal Pap tests and cervical—and other—cancers. People must understand these issues to make informed decisions about the new vaccines to prevent HPV-caused diseases. This section explains what HPVs are, how the genital types are acquired, what happens once someone is infected, and discusses strategies for the prevention of genital HPV infections, including strategies for using the new vaccines.
-
This article explains why women who have sex with other women should receive the vaccine HPV vaccine.
-
Many states are considering whether or not to mandate HPV vaccine for school entry for sixth grade and above. What are the issues pro and con regarding HPV vaccine mandates?
-
Human papillomaviruses (HPVs) are a group of more than 120 different viruses, some of which cause cervical cancer. A new vaccine against HPV will soon be available.
-
A potential tool for preventing HPV infections and thus cervical and anogenital cancers are vaccines. Will these vaccines be effective?
On May 23, 2006, NNii hosted a telebriefing about HPV and HPV vaccines. Experts talked about the epidemiology and risk factors of HPV infections, the relationship of HPV to cervical cancer, and why the vaccine — which prevents a sexually transmitted disease — will be targeted to preteens as well as to adolescents and young adults.
